The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 1, 1998, Pages 105-115

  Fowble, B ^a   Hanlon, A L ^a   Patchefsky, A ^a   Freedman, G ^a   Hoffman, J P ^a   Sigurdson, E R ^a   Goldstein, L J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Conservative surgery; Ipsilateral breast tumor recurrence; Radiation

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN REPLACEMENT THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0031671244     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00181-3     Document Type: Article

References (46)

1. Harris, J. R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int. J. Radiat. Oncol. Biol. Phys. 35:641-648; 1996.
2. Gage, I.; Schnitt, S. J.; Nixon, A. J.; Silver, B.; Recht, A.; Troyan, S. L.; Eberlein, T.; Love, S. M.; Gelman, R.; Harris, J. R.; Connelly, J. L. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928; 1996.
3. Jacquemier, J.; Kurtz, J. M.; Amalric, R.; Brandone, H.; Ayme, Y.; Spitalier, J. M. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br. J. Cancer 61:873-876; 1990.
4. Veronesi, U.; Marubini, E.; Delvecchio, M.; Manzari, A.; Andreola, S.; Greco, M.; Luini, A.; Merson, M.; Saccozzi, R.; Rilke, F.; Salvadori, B. Local and distant metastases after conservative breast cancer treatments: party independent events. J. Nat. Cancer Inst. 87:19-27; 1995.
5. Yeh, I. T.; Fowble, B.; Viglione, M. J.; LiVolsi, V. A.; Schultz, D. J. Pathologic assessment and pathologic prognostic factors in operable breast cancer. In: Fowble, B.; Goodman, R. L.; Glick, J. H.; Rosato, E. F., eds. Breast cancer treatment: A comprehensive guide to management. St. Louis: C. V. Mosby Co.; 1991:167-208.
6. Fein, D. A.; Fowble, B. L.; Hanlon, A. L. The influence of pathologic margin status, adjuvant treatment and residual tumor within the re-excision specimen on breast recurrence (Abstr.) Int. J. Radiat. Oncol. Biol. Phys. 36:275; 1996.
7. Komarnicky, L. T.; Mansfield, C. M.; DiBiase, S. J. Prognostic significance of the number of positive margins in breast conserving treatment for early-stage breast cancer. Proceedings of the American Radium Society 79th Annual Meeting (Abstr.) Cancer J. Sci. Am. 3:119; 1997.
8. Pittinger, T. P.; Maronian, N. C.; Poulter, C. A.; Peacock, J. L. Importance of margin status and outcome of breast conserving surgery for carcinoma. Surgery 116:605-609; 1994.
9. Fisher, E. R.; Costantino, J.; Fisher, B.; Palekar, A. S.; Paik, S. M.; Suarez, C. M.; Wolmark, N.; for the National Surgical Adjuvant Breast and Powel Project Collaborating Investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 78:1403-1416; 1996.
10. Fowble, B. In-situ breast cancer. In: Fowble, B.; Goodman, R. L.; Glick, J. H.; Rosato, E. F., eds. Breast cancer treatment: A comprehensive guide to management. St. Louis: Mosby; 1991:325-344.
11. Morrow, M. Pre-cancerous breast lesions: Implications for breast cancer prevention trials. Int. J. Radiat. Oncol. Biol. Phys. 23:1071-1078; 1992.
12. Rosen, P. P.; Kosloff, C.; Lieberman, P. H.; Adair, F.; Braum, D. W. J. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am. J. Surg. Pathol. 2:225-251; 1978.
13. Page, D. L.; Jensen, R. A. Evaluation and management of high risk and premalignant lesions of the breast. World J. Surg. 18:32-38; 1994.
14. Page, D. L.; Kidd, T. E. J.; Dupont, W. D.; Simpson, J. F.; Rogers, L. W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Human Pathol. 22:1232-1239; 1991.
15. Bodian, C. A.; Perzin, K. H.; Lattes, R.; Hoffman, P.; Abernathy, T. G. Prognostic significance of benign proliferative breast disease. Cancer 71:3896-3907; 1993.
16. Dupont, W. D.; Page, D. L. Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 312:146-151; 1985.
17. Dupont, W. D.; Pari, F. F.; Hartmann, W. H.; Brinton, L. A.; Winfield, A. C.; Worrell, J. A.; Schuyler, P. A.; Plummer, W. D. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258-1265; 1993.
18. London, S. J.; Connolly, J. L.; Schnitt, S.; Colditz, G. A. A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944; 1992.
19. Page, D. L.; Dupont, W. D.; Rogers, L. W.; Rados, M. S. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer 55:2268-2708; 1985.
20. Palli, D.; Roselli del Turco, M.; Simoncini, R.; Bianchi, S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int. J. Cancer 47:703-706; 1991.
21. Rosen, P. P. Proliferative breast "disease". An unresolved diagnostic dilemma. Cancer 71:3798-3807; 1993.
22. Carter, C. L.; Corle, D. K.; Micozzi, M. S.; Schatzkin, A.; Taylor, P. R. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am. J. Epidemiol. 128:467-477; 1988.
23. Krieger, N.; Hiatt, R. A. Risk of breast cancer after benign breast disease. Variation by histologic type, degree of atypica, age of biopsy, and length of follow-up. Am. J. Epidemiol. 135:619-631; 1992.
24. McDivitt, R. W.; Stevens, J. A.; Lee, N. C.; Wingo, P. A.; Rubin, G. L.; Gersell, D. Histologic types of benign breast disease and the risk of breast cancer. JAMA 267:941-944; 1992.
25. Moran, M. S.; Haffty, B. G. Lobular carcinoma in-situ as a component of breast cancer: the long term outcome in patients treated with breast conservation therapy (Abstr.). Int. J. Radiat. Oncol. Biol. Phys. 36:214; 1996.
26. Schnitt, S.; Connolly, J.; Recht, A.; Bornstein, B.; Nixon, A.; Hetelikidis, S.; Silver, B.; Harris, J. Is the presence or extent of lobular carcinoma in situ related to the risk of local recurrence in patients with invasive breast cancer treated with conservative surgery and radiation therapy? (Abstr.). Breast Cancer Res. Treatment 41:224; 1996.
27. Schnitt, S. J.; Connolly, J. L.; Recht, A.; et al. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64:448-; 1989.
28. Fisher, E. R.; Anderson, S.; Redmond, C.; Fisher, B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathologic findings from NSABP B06. Semin. Surg. Oncol. 8:161-166; 1992.
29. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia, PA: J. P. Lippincott Co; 1983:127-134.
30. Tavassoli, F. A.; Norris, H. J. A comparison of results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518-529; 1990.
31. Tavassoli, F. A. Atypical hyperplasia: A morphologic risk factor for subsequent development of invasive breast carcinoma. Cancer Invest. 10:433-441; 1992.
32. Armitage, P. Statistical methods of medical research. New York: John Wiley & Sons, Inc; 1973:135-136.
33. Mehta, C. R.; Patel, H. R. A network of algorithm for performing Fisher's exact test in R cross C contingency tables. J. Am. Statist. Assoc. 78:427-434; 1983.
34. Kaplan, E. L.; Meier, P. Non-parametric estimation from incomplete observation. J. Am. Statist. Assoc. 53:457-481; 1958.
35. Mantel, M. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother. Rep. 50:163-170; 1966.
36. Connolly, J.; Schnitt, S.; London, S.; Dupont, W.; Colditz, G.; Page, D. Both atypical lobular hyperplasia (ALH) and atypical ductal hyperplasia (ADH) predict for bilateral breast cancer risk (Abstr.). Lab. Invest. 66:13; 1992.
37. Kodlin, D.; Winger, E. E.; Morgenstern, N. L.; Chen, V. Chronic mastopathy and breast cancer: a follow-up study. Cancer 39:2603-2607; 1977.
38. Dupont, W. D.; Page, D. L.; Rogers, L. W.; Pari, F. F. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk. Cancer 63:948-957; 1989.
39. Page, D. L.; Rogers, L. W. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Human Pathol. 23:1095-1097; 1992.
40. Page, D. L.; Anderson, T. J. Diagnostic histopathology of the breast. Edinburgh, UK: Churchill Livingstone; 1988:137-147.
41. Page, D. L.; Dupont, W. D. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66:1326-1335; 1990.
42. Rosai, J. Borderline epithelial lesions of the breast. Am. J. Surg. Pathol. 15:209-221; 1991.
43. Schnitt, S. J.; Connolly, J. L.; Tavassoli, F. A.; Fechner, R. E.; Kempson, R. L.; Gelman, R. Interobserver reproducibility in the diagnosis of ductal proliferative lesions using standardized criteria. Am. J. Surg. Pathol. 16:1133-1143; 1992.
44. Bodian, C. A.; Perzin, K. H.; Lattes, R.; Hoffmann, P. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer 71:3908-3913; 1993.
45. Connolly, J. L.; Schnitt, S. J. Benign breast disease. Resolved and unresolved issues. Cancer 71:1187-1189; 1993.
46. Rubin, E.; Visscher, D. W.; Alexander, R. W.; Wrist, M. M.; Maddox, W. A. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer 61:2077-2082; 1988.